The capabilities of the internal audit function may lag behind the pressing business needs of pharmaceutical, biotechnology, and medical device organizations. If this is the case, a transformation program can correct misalignment between longstanding IA procedures and what is needed now by the board. IA transformation seeks to develop internal resources with deep business knowledge and the agility to keep up with the pace of innovation.
